Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular Diagnostics.

ALK mutation ALK-inhibitor MYCN amplification cancer detection of therapeutic targets liquid biopsy minimal residual disease precision medicine real-time monitoring of therapeutic efficacy

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
21 Apr 2022
Historique:
received: 20 03 2022
revised: 15 04 2022
accepted: 19 04 2022
entrez: 14 5 2022
pubmed: 15 5 2022
medline: 15 5 2022
Statut: epublish

Résumé

Liquid biopsy strategies in pediatric patients are challenging due to low body weight. This study investigated cfDNA size distribution and concentration in blood, bone marrow, cerebrospinal fluid, and urine from 84 patients with neuroblastoma classified as low (

Identifiants

pubmed: 35565208
pii: cancers14092080
doi: 10.3390/cancers14092080
pmc: PMC9099910
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : European Union
ID : 01KT1902
Organisme : German Cancer Aid
ID : 70112951
Organisme : Berlin Institute of Health
ID : CRG-04 TERMINATE-NB
Organisme : Federal Ministry of Education and Research
ID : 161L0220A

Références

PLoS One. 2017 Nov 21;12(11):e0188174
pubmed: 29161279
Cancer Cell Int. 2018 Feb 17;18:21
pubmed: 29467591
Eur J Cancer. 2022 Jan;160:12-23
pubmed: 34794856
Cell Tissue Res. 2018 May;372(2):277-286
pubmed: 29305654
Clin Cancer Res. 2020 Mar 15;26(6):1309-1317
pubmed: 31852832
BMC Cancer. 2020 Feb 6;20(1):102
pubmed: 32028911
Nat Rev Dis Primers. 2016 Nov 10;2:16078
pubmed: 27830764
PLoS One. 2016 Aug 11;11(8):e0161039
pubmed: 27513929
J Clin Oncol. 2005 Dec 1;23(34):8919-20; author reply 8920
pubmed: 16314658
Clin Biochem Rev. 2008 Aug;29 Suppl 1:S49-52
pubmed: 18852857
Clin Cancer Res. 2022 May 2;28(9):1809-1820
pubmed: 35247920
Front Cell Dev Biol. 2020 Feb 18;8:45
pubmed: 32133357
Hematol Oncol Clin North Am. 2010 Feb;24(1):65-86
pubmed: 20113896
Eur J Cancer. 2009 Jan;45(2):228-47
pubmed: 19097774
Clin Cancer Res. 2016 Nov 15;22(22):5564-5573
pubmed: 27440268
JCO Precis Oncol. 2018;2018:
pubmed: 30027144
Oncotarget. 2017 Jul 7;8(49):85234-85251
pubmed: 29156716
Cancer Res. 2002 Jul 1;62(13):3646-8
pubmed: 12097268
Oncogene. 2021 Aug;40(33):5204-5212
pubmed: 34230613
Biotechniques. 2018 May;64(5):225-230
pubmed: 29793362
Cancer Treat Rev. 2020 Feb;83:101951
pubmed: 31874446
Nat Genet. 2013 Jan;45(1):12-7
pubmed: 23202128
Cancer Med. 2019 Apr;8(4):1558-1566
pubmed: 30793512
Nat Immunol. 2021 Dec;22(12):1577-1589
pubmed: 34811546
Clin Cancer Res. 2018 Feb 15;24(4):939-949
pubmed: 29191970
J Clin Oncol. 2005 Aug 1;23(22):5205-10
pubmed: 16051962
Cancer Res. 1977 Mar;37(3):646-50
pubmed: 837366
Pediatr Blood Cancer. 2009 Sep;53(3):329-31
pubmed: 19301388
Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16266-71
pubmed: 18838674
J Mol Diagn. 2020 Nov;22(11):1309-1323
pubmed: 32858250
Pediatr Surg Int. 2013 Nov;29(11):1139-45
pubmed: 24022278
Klin Padiatr. 2017 May;229(3):147-167
pubmed: 28561228
Cancers (Basel). 2021 Jul 05;13(13):
pubmed: 34282791
Clin Cancer Res. 2017 Oct 15;23(20):6305-6314
pubmed: 28710315
J Mol Diagn. 2020 Aug;22(8):1070-1086
pubmed: 32497717
Sci Transl Med. 2014 Feb 19;6(224):224ra24
pubmed: 24553385
Nat Commun. 2021 Nov 23;12(1):6804
pubmed: 34815394
J Pediatr Hematol Oncol. 2021 Mar 1;43(2):e165-e168
pubmed: 32032241
J Pediatr Surg. 2015 Dec;50(12):2094-7
pubmed: 26388126
Oncotarget. 2016 Oct 25;7(43):71013-71035
pubmed: 27589834
Mol Aspects Med. 2020 Apr;72:100819
pubmed: 31563277
Paediatr Drugs. 2017 Dec;19(6):577-593
pubmed: 28786082
Lancet. 2007 Jun 23;369(9579):2106-20
pubmed: 17586306
JCO Precis Oncol. 2021 Nov 17;5:
pubmed: 34820594
Clin Cancer Res. 2008 Nov 1;14(21):7011-9
pubmed: 18980997
Cancer Med. 2015 Apr;4(4):540-50
pubmed: 25653133
Clin Cancer Res. 2016 Feb 1;22(3):546-52
pubmed: 26503946
Eur J Pediatr. 2020 Feb;179(2):191-202
pubmed: 31897843
Pediatr Blood Cancer. 2011 May;56(5):757-61
pubmed: 21370407
Pediatr Blood Cancer. 2011 May;56(5):865-7
pubmed: 21370425
Cancer Med. 2018 Jun 14;:
pubmed: 29905010
JCO Precis Oncol. 2020 Apr 14;4:
pubmed: 32923888
Cancer Lett. 2011 Oct 28;309(2):185-9
pubmed: 21726937
Lancet Oncol. 2021 Dec;22(12):1764-1776
pubmed: 34780709

Auteurs

Marco Lodrini (M)

Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125 Berlin, Germany.
Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125 Berlin, Germany.
German Cancer Consortium (DKTK), Partner Site Berlin, 10117 Berlin, Germany.
German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Jasmin Wünschel (J)

Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125 Berlin, Germany.
Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125 Berlin, Germany.

Theresa M Thole-Kliesch (TM)

Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.

Maddalena Grimaldi (M)

Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125 Berlin, Germany.
Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125 Berlin, Germany.

Annika Sprüssel (A)

Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.

Rasmus B Linke (RB)

Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.

Jan F Hollander (JF)

Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.

Daniela Tiburtius (D)

Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
German Cancer Consortium (DKTK), Partner Site Berlin, 10117 Berlin, Germany.
German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Annette Künkele (A)

Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
German Cancer Consortium (DKTK), Partner Site Berlin, 10117 Berlin, Germany.
German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.

Johannes H Schulte (JH)

Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
German Cancer Consortium (DKTK), Partner Site Berlin, 10117 Berlin, Germany.
German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.

Erwin Lankes (E)

Department of Pediatric Endocrinology and Diabetes, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Center for Chronically Sick Children, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.

Thomas Elgeti (T)

Department of Radiology (Including Pediatric Radiology), Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.

Patrick Hundsdörfer (P)

Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Department of Pediatric Oncology, Helios Klinikum Berlin Burch, 13125 Berlin, Germany.

Kathy Astrahantseff (K)

Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.

Thorsten Simon (T)

Department of Pediatric Oncology and Hematology, Children's Hospital, University of Cologne, 50924 Cologne, Germany.

Angelika Eggert (A)

Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
German Cancer Consortium (DKTK), Partner Site Berlin, 10117 Berlin, Germany.
German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.

Hedwig E Deubzer (HE)

Department of Pediatric Hematology and Oncology, Charité-Universitätsmedizin Berlin, 13353 Berlin, Germany.
Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125 Berlin, Germany.
Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, 13125 Berlin, Germany.
German Cancer Consortium (DKTK), Partner Site Berlin, 10117 Berlin, Germany.
German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.

Classifications MeSH